Abstract
The epidemiology of sexually transmitted infections (STIs) is ever-changing and reflects the prevalent sexual behaviors and the health-care services in the community. Knowledge of the various epidemiological factors is essential for designing effective control strategies. Developing nations account for the vast share of STIs, while the STI burden is quite low in the developed world. With the emergence of HIV infection, indiscriminate use of antibiotics, upgradation of health-care facilities at primary level, and success of a syndromic approach to STI treatment, we are currently witnessing a decline in bacterial STIs and a surge in viral infections. This change in the STI trends is common to both developing as well as developed countries. However, our understanding of the epidemiology of STIs in developing nations is limited by lack of good-quality community-based data: most of the data available are institution-based, with surveys in convenient populations like STI clinics or antenatal clinic attendees, which is not representative of the general population.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Newman L, Rowley J, Vander Hoorn S, et al. Global estimates of the prevalence and incidence of four curable sexually transmitted infections in 2012 based on systematic review and global reporting. PLoS One. 2015;10:e0143304.
Savage EJ, Hughes G, Ison C, et al. Syphilis and gonorrhoea in men who have sex with men: a European overview. Euro Surveill Bull Eur Sur Mal Transm Eur Commun Dis Bull. 2009;14(47).
Workowski KA, Bolan GA. Sexually transmitted diseases treatment guidelines, 2015. MMWR Recomm Rep. 2015;64:1.
González-Beiras C, Marks M, Chen CY, et al. Epidemiology of Haemophilus ducreyi infections. Emerg Infect Dis. 2016;22:1–8.
Sexually transmitted disease surveillance. 2014. http://www.cdc.gov/std/stats
Hook EW, Handsfield HH. Gonococcal infections in adults. In: Holmes KK, Sparling PF, Stamm WE, Piot P, Wasserheit JN, Corey L, Cohen MS, Watts DH, editors. Sexually transmitted diseases. 4th ed. New York: McGraw-Hill; 2007.
Unemo M, del Rio C, Shafer WM. Antimicrobial resistance expressed by Neisseria gonorrhoeae: a major global public health problem in the 21st century. Microbiol Spectr. 2016;4(3).
Malhotra M, Sood S, Mukherje A, et al. Genital chlamydia trachomatis: an update. Indian J Med Res. 2013;138(3):303–16.
Workowski KA, Berman S, Centers for Disease Control and Prevention (CDC). Sexually transmitted diseases treatment guidelines, 2010. MMWR Recomm Rep. 2010;59(RR-12):1–110.
Abu-Raddad LJ, Schiffer JT, Ashley R, et al. HSV-2 serology can be predictive of HIV epidemic potential and hidden sexual risk behavior in the Middle East and North Africa. Epidemics. 2010;2:173–82.
Swygard H, Seña AC, Hobbs MM, et al. Trichomoniasis: clinical manifestations, diagnosis and management. Sex Transm Infect. 2004;80:91–5.
Sorvillo F, Smith L, Kerndt P, et al. Trichomonas vaginalis, HIV, and African-Americans. Emerg Infect Dis. 2001;7:927–32.
Nye MB, Schwebke JR, Body BA. Comparison of APTIMA trichomonas vaginalis transcription-mediated amplification to wet mount microscopy, culture, and polymerase chain reaction for diagnosis of trichomoniasis in men and women. Am J Obstet Gynecol. 2009;200:188.e1–7.
Looker KJ, Magaret AS, Turner KME, Vickerman P, Gottlieb SL, Newman LM. Global estimates of prevalent and incident herpes simplex virus type 2 infections in 2012. PLoS One. 2015;10:e114989.
Gupta V, Bhari N, Gupta S. Genital herpes. http://www.aaus.info/mediawiki/index.php/Genital_herpes
Patel H, Wagner M, Singhal P, et al. Systematic review of the incidence and prevalence of genital warts. BMC Infect Dis. 2013;13:39.
de Sanjosé S, Diaz M, Castellsagué X, et al. Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis. Lancet Infect Dis. 2007;7:453–9.
Clifford GM, Rana RK, Franceschi S, et al. Human papillomavirus genotype distribution in low-grade cervical lesions: comparison by geographic region and with cervical cancer. Cancer Epidemiol Biomark Prev. 2005;14:1157–64.
Kumar P, Dar L, Saldiwal S, et al. Intralesional injection of mycobacterium w vaccine vs imiquimod, 5%, cream in patients with anogenital warts: a randomized clinical trial. JAMA Dermatol. 2014;150:1072–8.
Latif AS. The syndromic approach for the management of STIs: an overview. In: Gupta S, Kumar B, editors. Sexually transmitted infections. 2nd ed. New York: Elsevier; 2012.
Amin AR. Enhanced syndromic case management of reproductive tract infection/sexually transmitted infection cases as per National AIDS Control Organization guidelines. Indian J Sex Transm Dis. 2010;31:61–2.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG, part of Springer Nature
About this chapter
Cite this chapter
Gupta, V., Zaghloul, A.B., Gupta, S. (2018). Sexually Transmitted Infections in Dark Skin. In: Orfanos, C., Zouboulis, C., Assaf, C. (eds) Pigmented Ethnic Skin and Imported Dermatoses. Springer, Cham. https://doi.org/10.1007/978-3-319-69422-1_8
Download citation
DOI: https://doi.org/10.1007/978-3-319-69422-1_8
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-69421-4
Online ISBN: 978-3-319-69422-1
eBook Packages: MedicineMedicine (R0)